Secondary Hyperparathyroidism in Haemodialysis Patients (Paperback)

Secondary hyperparathyroidism (SHPT) develops frequently in patients with "End Stage Renal Disease" because the production of 1, 25 (OH) 2- vitamin D (calcitriol) decreases in the kidneys. That's why patients may develop osteodystrophy or osteomalacia. The functional role of vitamin D3 under normal body condition is to regulate secretion of parathyroid hormone (PTH) synthesis and release. Parameters such as calcium, phosphate and vitamin D3 act upon PTH. In normal subjects, the homeostasis of these parameters is strongly interconnected but in renal failure, the metabolism of each of these parameters may be deregulated. The diseased kidney is unable to produce vital hormone that is called erythropoietin which increases synthesis of red blood cells. The anemic condition is seen in CKD (chronic kidney disease) because erythropoietin production become reduced. In Pakistan, CKD patients are continuously increasing annually. We conducted a blood and serosurvey study in Lahore metropolitan city of Punjab, Pakistan to see the co-relation between SHPT and CKD. This epidemiological research of public health will be beneficial for onward broad demographic surveillance programs.

General

Imprint:	Lap Lambert Academic Publishing
Country of origin:	Germany
Release date:	2012
First published:	2012
Authors:	Samreen Khan • Husna Malik • Iahtasham Khan
Dimensions:	229 x 152 x 10mm (L x W x T)
Format:	Paperback - Trade
Pages:	172
ISBN-13:	978-3-8473-0315-2
Categories:	Books > Science & Mathematics > Biology, life sciences > Biochemistry > General
LSN:	3-8473-0315-5
Barcode:	9783847303152

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!